ArticleJournal of education and health promotion2025
Creation and validation of a daily task reminder clock for people with dementia in a Pune dementia center.
Article in Journal of education and health promotion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis mixed-method study aimed to develop and validate an activity reminder clock for dementia through user testing and feedback. The increasing prevalence of dementia worldwide presents significant challenges for both patients and caregivers. Dementia impairs cognitive functions, complicating daily routines and management of everyday tasks. As the disease progresses, patients often struggle with time management and maintaining a structured routine, which can lead to increased confusion and reduced quality of life. Assistive technologies, such as activity reminder clocks, have emerged as potential solutions to help address these challenges. These devices are designed to aid individuals with dementia by providing reminders for daily activities, which can help them maintain a sense of normalcy and independence. MATERIALS AND
methodsThe study was done in three main stages: the qualitative phase (phase 1), the device development phase (phase 2), and the quantitative phase (phase 3). The study's two sections consist of demographic and semi-structured interview questions. The semi-structured survey instrument was created for Interviews with medical professionals and caregivers and included expectations for this kind of technology, as well as opinions on the necessity of an activity reminder clock and the difficulties involved in caring for dementia patients. During the qualitative phase, interviews with physicians and caregivers revealed themes such as the advantages of assistive technology and difficulties with implementation. Thematic analysis influenced the development of the user-friendly activity reminder clock. In the subsequent quantitative study, which had thirty participants, a Likert scale was used to assess effectiveness.
resultsThe results revealed a resounding yes (86.67%), with 93.33% of participants thinking the reminder clock was essential for dementia care. A whopping 93% of the participants expressed satisfaction with its usability, affordability, and convenience of use. Fisher's exact tests revealed a significant correlation between age and recommending the device to others (
conclusionThe study highlights the reminder clock's effectiveness and utility in enhancing daily tasks. Everyone agrees that it is necessary, logical, and beneficial. The findings indicate that age affects suggestions for device adoption and Favors tailored technology interventions to improve the quality of life for dementia patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.